The Bcl-2/xL inhibitor ABT-263 increases the stability of Mcl-1 mRNA and protein in hepatocellular carcinoma cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Bcl-2/xL inhibitor ABT-263 increases the stability of Mcl-1 mRNA and protein in hepatocellular carcinoma cells
Authors
Keywords
ABT-263, Mcl-1, Stability, HCC
Journal
Molecular Cancer
Volume 13, Issue 1, Pages 98
Publisher
Springer Nature
Online
2014-04-30
DOI
10.1186/1476-4598-13-98
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BH3 mimetics reduce adhesion and migration of hepatoblastoma and hepatocellular carcinoma cells
- (2013) Fabian Vogt et al. EXPERIMENTAL CELL RESEARCH
- YM-155 Potentiates the Effect of ABT-737 in Malignant Human Glioma Cells via Survivin and Mcl-1 Downregulation in an EGFR-Dependent Context
- (2013) E. P. Jane et al. MOLECULAR CANCER THERAPEUTICS
- The novel BH-3 mimetic apogossypolone induces Beclin-1- and ROS-mediated autophagy in human hepatocellular carcinoma cells
- (2013) P Cheng et al. Cell Death & Disease
- Dual Inhibition of Bcl-2 and Bcl-xL Strikingly Enhances PI3K Inhibition-Induced Apoptosis in Human Myeloid Leukemia Cells through a GSK3- and Bim-Dependent Mechanism
- (2012) M. Rahmani et al. CANCER RESEARCH
- Mcl-1 Phosphorylation Defines ABT-737 Resistance That Can Be Overcome by Increased NOXA Expression in Leukemic B cells
- (2012) S. Mazumder et al. CANCER RESEARCH
- Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer
- (2012) C. M. Rudin et al. CLINICAL CANCER RESEARCH
- Targeting the B-Cell Lymphoma/Leukemia 2 Family in Cancer
- (2012) Matthew S. Davids et al. JOURNAL OF CLINICAL ONCOLOGY
- Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration
- (2012) Rhonda M. Perciavalle et al. NATURE CELL BIOLOGY
- Molecular Targeted Therapies in Hepatocellular Carcinoma
- (2012) Shinji Tanaka et al. SEMINARS IN ONCOLOGY
- Regulation of mitochondrial metabolism: yet another facet in the biology of the oncoprotein Bcl-2
- (2011) Shefali Krishna et al. BIOCHEMICAL JOURNAL
- Activation of ATF4 mediates unwanted Mcl-1 accumulation by proteasome inhibition
- (2011) J. Hu et al. BLOOD
- ABT-263 sensitizes TRAIL-resistant hepatocarcinoma cells by downregulating the Bcl-2 family of anti-apoptotic protein
- (2011) Guan Wang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Targeting Mcl-1 for the therapy of cancer
- (2011) Bridget A Quinn et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors
- (2011) Leena Gandhi et al. JOURNAL OF CLINICAL ONCOLOGY
- MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complex
- (2011) M Konopleva et al. LEUKEMIA
- Sorafenib Sensitizes (-)-Gossypol-Induced Growth Suppression in Androgen-Independent Prostate Cancer Cells via Mcl-1 Inhibition and Bak Activation
- (2011) J. Lian et al. MOLECULAR CANCER THERAPEUTICS
- Survivin Inhibition Is Critical for Bcl-2 Inhibitor-Induced Apoptosis in Hepatocellular Carcinoma Cells
- (2011) Xiangxuan Zhao et al. PLoS One
- Mcl-1; the molecular regulation of protein function
- (2010) Luke W. Thomas et al. FEBS LETTERS
- The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib
- (2010) Hayato Hikita et al. HEPATOLOGY
- Clinical significance of Cox-2, Survivin and Bcl-2 expression in hepatocellular carcinoma (HCC)
- (2010) Yu Yang et al. MEDICAL ONCOLOGY
- Antiapoptotic Effect of c-Jun N-terminal Kinase-1 through Mcl-1 Stabilization in TNF-Induced Hepatocyte Apoptosis
- (2009) Yuzo Kodama et al. GASTROENTEROLOGY
- Mcl-1 Integrates the Opposing Actions of Signaling Pathways That Mediate Survival and Apoptosis
- (2009) C. Morel et al. MOLECULAR AND CELLULAR BIOLOGY
- Translation inhibition during cell cycle arrest and apoptosis: Mcl-1 is a novel target for RNA binding protein CUGBP2
- (2008) Dharmalingam Subramaniam et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Bcl-2 Family Proteins Contribute to Apoptotic Resistance in Lung Cancer Multicellular Spheroids
- (2008) Tsung-Ming Yang et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
- (2008) C. Tse et al. CANCER RESEARCH
- BCL-2 family antagonists for cancer therapy
- (2008) Guillaume Lessene et al. NATURE REVIEWS DRUG DISCOVERY
- mTORC1 promotes survival through translational control of Mcl-1
- (2008) J. R. Mills et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started